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Abstract
Background—Reactive aldehydes like acetaldehyde and malondialdehyde generated as a result 
of alcohol metabolism and cigarette smoke exposure lead to the formation of malondialdehyde-
acetaldehyde-adducted proteins (MAA adducts). These aldehydes can adduct to different proteins 
such as bovine serum album (BSA) and surfactant proteins A or D (SPA, SPD). Macrophages play 
an important role in innate immunity, but the effect of MAA adducts on macrophage function has 
not yet been examined. Because macrophage scavenger receptor A (SRA; CD204) mediates the 
uptake of modified proteins, we hypothesized that the effects of MAA modified proteins on 
macrophage function are primarily mediated through SRA.
Methods and Results—We tested this hypothesis by exposing SPD-MAA to macrophages and 
measuring functions. SPD-MAA treatment significantly stimulated pro-inflammatory cytokine 
TNF-α release in the macrophage cell line, RAW 264.7. A significant reduction in phagocytosis of 
zymosan particles was also observed. SPD-MAA stimulated a significant dose-dependent increase 
in TNF-α and IL-6 release from peritoneal macrophages of WT mice. But a significantly less 
TNF-α and IL-6 were released from peritoneal macrophages of SRA−/− mice. We observed a 
significant reduction in phagocytosis of zymosan particles in peritoneal macrophages from WT 
mice treated with SPD-MAA. No further SPD-MAA-induced reduction was seen in peritoneal 
macrophages form SRA−/− mice. SPD-MAA treatment significantly increased SRA mRNA 
expression, but had no effect on surface receptor protein expression. Protein kinase C alpha 
inhibitor and NF-κB inhibitor significantly reduced pro-inflammatory cytokine release in response 
to SPD-MAA.
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Conclusion—In conclusion, our data demonstrate that SRA is important for MAA-adducted 
protein-mediated effect on macrophage functions.
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INTRODUCTION
Alcohol intoxication compromises host defenses against bacterial infections as it leads to 
suppression of selected functions of the immune system (Nelson et al., 1989). Individuals 
with alcohol use disorders (AUDs) are more susceptible to bacterial pneumonia than those 
without AUDs. (Cook, 1998). In addition, persons with AUDs are two to three times more 
likely to smoke cigarettes (Bobo and Husten, 2000; Miller and Gold, 1998) leading to more 
frequent (John et al., 2003) and higher rates of cigarette smoking among AUDs than in the 
general population (Narahashi et al., 2001).
Macrophages are often called first responder phagocytes, ingesting and killing inhaled 
bacteria (Yang et al., 2014; Fujiwara and Kobayashi, 2005). They exhibit different 
anatomical and functional features depending upon their tissue location (Wynn et al., 2013). 
Macrophages exhibit an inflammatory phenotype and secrete pro-inflammatory mediators 
such as tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-6 and IL-1β, all of which 
participate in activation of antimicrobial mechanisms (Parihar et al., 2010). Macrophages 
also produce reactive oxygen and nitrogen intermediates like nitric oxide and superoxide as 
a defense mechanism against microorganisms (Murray and Wynn, 2011). Because 
macrophages play an important role in antimicrobial defense as well as to initiate, maintain, 
and resolve inflammation (Fujiwara and Kobayashi, 2005), any compromise in antimicrobial 
defense could lead to increased susceptibility to infection and unchecked inflammation 
resulting in cellular and tissue damage.
Because both acute and chronic alcohol consumption lowers the ability of phagocytes to 
clear diverse pathogens, alcohol consumption often leads to lower/compromised innate and 
acquired immune response (Asplund et al., 2013). Short and long-term alcohol intake has 
also been shown to reduce phagocytic function of macrophages, which might play a role in 
increasing the risk of infection (Castro et al., 1993; Bagasra et al., 1988). Alcohol 
consumption, both acute and chronic, alters pro-inflammatory cytokine production. In acute 
or moderate alcohol consumption, the release of pro-inflammatory cytokines TNF alpha, 
IL-6 and IL-1 from monocytes is decreased. This could also contribute to compromised 
immunity, as these cytokines are important for defense against pathogens (Mandrekar et al., 
2009). In contrast to this, chronic alcohol consumption leads to increased pro-inflammatory 
cytokine release, which could result in uncontrolled inflammation (Mandrekar et al., 2009; 
Szabo, 1997).
Reactive aldehydes such as acetaldehyde and malondialdehyde are formed during alcohol 
metabolism and oxidative stress in response to excessive alcohol consumption (Tuma and 
Casey, 2003; Sapkota et al., 2014). These aldehydes, once formed, react together covalently 
with proteins and generate MAA adducts, which possess immunogenic and pro-
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inflammatory properties (Tuma, 2002). In addition to alcohol, these reactive aldehydes could 
also form as a result of cigarette smoking and bind to protein and other molecules 
(McCaskill et al., 2011). During co-exposure to alcohol and cigarette smoke, high 
concentrations of acetaldehyde and malondialdehyde are generated resulting in formation of 
MAA adducts (McCaskill et al., 2011; Wyatt et al., 2001). In lung, MAA covalently binds to 
surfactant protein D (SPD) secreted by type II epithelial cells to form an adducted protein 
called SPD-MAA (McCaskill et al., 2011).
Scavenger receptors are pattern recognition receptors expressed on the surface of 
macrophages (Peiser et al., 2002). Among them, macrophage scavenger receptor A (SRA; 
CD204) has been the most widely studied (Haworth et al., 1997). SRA has the ability to bind 
and mediate the cellular uptake of modified lipoproteins (LDL) (Fitzgerald et al., 2000). In 
addition to modified LDL, this receptor binds to many different ligands such as maleylated 
bovine serum albumin (BSA), polyribonucleotides, polysaccharides, and aldehyde-modified 
proteins (de Winther et al., 2000; Duryee et al., 2005; Berger et al., 2014).
MAA-adducted proteins have been shown to be ligands for SRA on liver cells and bronchial 
epithelial cells (Duryee et al., 2005; Berger et al., 2014). While the effects on hepatic stellate 
(Kharbanda et al., 2001), liver endothelial and Kupffer cells (Duryee et al., 2004) and airway 
epithelial cells (Berger et al., 2014) have been reported, the effects of MAA on major 
macrophage functions and the role of SRA on such effects have not been evaluated. In 
addition, SPD-MAA, a biologically relevant protein adduct, has been never used in studies 
of macrophage functions. We, therefore, hypothesized that SPD-MAA, a protein adduct 
relevant to aldehyde formation in smokers who drink alcohol, modulates macrophage 
functions primarily via SRA, one of the major receptor for MAA.
MATERIALS AND METHODS
Materials
Protein kinase C (PKC) beta inhibitor LY316976 was purchased from Bio-Techne 
(Minneapolis, MN), PKC delta inhibitor Rottlerin and PKC alpha inhibitor Gö 6976 were 
purchased from Millipore (Billerica, MA). PKC zeta inhibitor myristolated PKC zeta 
inhibitory peptide and PKC epsilon inhibitor Ro 31-8220 were purchased from Enzo life 
science (Farmingdale, NY). Phorbol myristate acetate (PMA), nitro blue tetrazolium (NBT), 
fucoidan, fetuin and parthenolide were purchased from Sigma Aldrich (St Louis, MO). 
Lipopolysaccharide (LPS) was purchased from Fisher Scientific (Pittsburg, PA). Rat Anti-
mouse SRA (2F8) was purchased from AbD Serotec (Raleigh, NC) and isotype negative 
control was purchased from Biolegend (San Diego, CA).
Cell culture and reagents
RAW 264.7 macrophages were purchased from American Type Cell Culture (ATCC, 
Rockville, MD) and cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin and maintained 
at 37°C in a humidified CO2 incubator. Resident peritoneal macrophages were isolated from 
C57BL/6 wild type mice (Charles River, Wilmington, MA) and SR-A knockout mice bred 
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from homozygous SRA deficient mice (−/−) (B6.Cg-Msr1tm1Csk/J; Jackson Laboratory, Bar 
Harbor, ME) as described previously (Zhang et al., 2008). All experimental animal 
procedures were reviewed and approved by the Institutional Animal Care and Use 
Committee at the University of Nebraska Medical Center. Briefly, peritoneal macrophages 
(PMs) were isolated by adherence to 24-well, flat-bottom, tissue culture-treated polystyrene 
plastic plates in which 1 × 106 peritoneal exudate cells were seeded per well and allowed to 
adhere for 2 h after which any non-adherent cells were washed away. At this point, the cells 
were 90% macrophages as confirmed by Diff-Quik™ Stain (Siemens Health Care 
Diagnostic Inc, Newark, DE). Isolated peritoneal macrophages were used for selective 
experiments.
Malondialdehyde-acetaldehyde synthesis
Human surfactant protein D (SPD) adducted to MAA (SPD-MAA) was prepared as 
previously reported (Wyatt et al., 2012). Briefly, approximately 1–1.5 mg/mL of SPD was 
incubated with 1.0 mM acetaldehyde and 1.0 mM MDA in pyrogen-free PBS. The pH was 
brought to 7.4, and maintained at 37 °C for 72 h. At the end of incubation, the reaction 
mixture was exhaustively dialyzed against pyrogen-free phosphate buffer solution for 24 h at 
4 °C. The endotoxin level in the MAA-SPD was measured by limulus assay and was below 
the limit of detection.
Pro-inflammatory cytokine release (TNFα and IL-6)
To identify the role of SPD-MAA on pro-inflammatory cytokine release, RAW 264.7 and 
resident peritoneal macrophages (PMs) were treated with different concentrations of SPD-
MAA (10–200 µg/mL) for different times (6–48 h). The supernatant was then collected and 
stored at -80 °C for later analysis. To block SRA, RAW 264.7 macrophages were pre-
incubated with fucoidan (50 µg/mL) for 72 h or anti-SRA (10 µg /mL) for 24 h followed by 
addition of SPD-MAA for another 6 h.
PKC isoform inhibition
To identify the role of PKC on MAA adduct-mediated pro-inflammatory cytokine release, 
RAW 264.7 macrophages were pre-incubated with different isoform-specific inhibitors to 
PKC beta (LY316976), PKC delta (Rottlerin), PKC zeta (myristolated PKC zeta inhibitory 
peptide), PKC alpha (Gö 6976) and PKC epsilon (Ro 31-8220) at 1 µM concentration for 1 h 
followed by addition of 200 µg/mL of SPD MAA for another 6 h. Resident peritoneal 
macrophages (PMs) were incubated with PKC alpha isoform inhibitor, Gö 6976 (1 µM) for 
1 h followed by SPD-MAA treatment for 6 h. After 6 h, supernatant was collected and later 
analyzed for cytokines levels.
NF-κB inhibition
To identify the role of NF-κB in MAA adduct-mediated pro-inflammatory cytokine release, 
macrophages were pre-incubated with 1 µM parthenolide for 1 h followed by 200 µg/mL 
SPD-MAA treatment for another 6 h. After 6 h, supernatant was collected and later analyzed 
for pro-inflammatory cytokines.
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ELISA
TNFα and IL-6 levels in the supernatant were measured by ELISA according to the 
manufacturer’s instructions (R & D Systems, Minneapolis, MN).
Phagocytosis
Phagocytosis of zymosan particles was assayed using a commercially available kit (Cell 
Biolabs, San Diego, CA). First, the macrophages were treated with 200 µg/mL SPD-MAA 
for 3 h followed by addition of zymosan particles (5 × 106) for (0–60) min and later 
analyzed for phagocytosis of the zymosan by measuring the optical density at 430 nm 
according to manufacturer instructions. For PMs, the macrophage were treated with 200 
µg/mL SPD-MAA for 3 h followed by addition of zymosan particles (5 × 106) for 30 min.
Superoxide ion production
PMA stimulated superoxide ion production—Superoxide ion production was assayed 
using previously established NBT method as previously described (Sim Choi et al., 2006). 
RAW 264.7 macrophages were pre-treated with 200 µg/mL SPD-MAA for 24 h after which, 
PMA (300 ng /mL) in NBT solution (1 mg/mL) was added to the macrophages. After 1 h, 
macrophages were washed with phosphate buffer saline (PBS, pH 7.4) twice and later fixed 
with 100% methanol. The plate was then allowed to air dry for 10 min. After the complete 
removal of methanol, 120 µL of 2M potassium hydroxide was added followed by addition of 
140 µL of 100 % dimethylsulfoxide and incubated at room temperature for 10 min. After 10 
min, 200 µL of the solution was transferred to another 96-well plate and optical density was 
measured at 630nm (BioTek Instruments, Inc, Winooski, VT).
Opsonized zymosan stimulated superoxide ion production—Opsonized zymosan 
was prepared using a previously established method (Suhonen et al., 2000). First 10 mg of 
zymosan A (Sigma Aldrich, St Louis, MO) was opsonized with 1 mL of normal mouse 
serum (Invitrogen, Frederick, MO) by incubating at 37°C for 30 min followed by washing 
with PBS (pH 7.4) twice. RAW 246.7 macrophages were pre-treated with 200 µg/mL SPD-
MAA for 24 h after which opsonized zymosan (1 mg/mL) in NBT solution (1 mg/mL) was 
added to the macrophages. After 30 min, macrophages were washed with PBS and 
superoxide ion production was measured as described above.
Nitrite production—Nitrite production was assayed by measuring nitrite (a stable 
degradation product of nitric oxide (NO) in the supernatant of cultured RAW 264.7 
macrophage using Griess reagent. Briefly, RAW 264.7 macrophages were pretreated with 
200 µg/mL of SPD-MAA for 3 h followed by treatment with 0.3 mg/mL zymosan (Sigma 
Aldrich, St Louis, MO) in Hams F-12 nutrient medium containing 10% FBS. After 24 h, 
supernatant was collected and nitrite level was measured using a commercial kit (Cayman 
Chemical, Ann Arbor, MI).
Real-time quantitative RT-PCR—RAW 264.7 macrophages were treated with SPD-
MAA (200 µg/mL) for (1–24 h) and later total RNA was isolated from the macrophages 
using RNeasy mini kit (Qiagen, Valencia, CA) according to the manufacturer’s instructions. 
The purity of RNA was checked by measurement of optical density (260/280) ratio using a 
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NanoDrop spectrophotometer (Thermoscientific). cDNA was synthesized using 100 ng of 
template RNA and a TaqMan reverse transcription kit (Applied Biosystems, Austin, TX). 
Real-time PCR reactions were prepared using TaqMan Master Mix (Applied Biosystems) 
and primers and probe for SRA (Applied Biosystems; Mm 00446214_m1). Ribosomal (18S) 
RNA was used as an endogenous control. PCR was performed using an ABI PRISM 7700 
Sequence Detection System (Applied Biosystems). Threshold values were normalized to the 
expression of ribosomal RNA. Real-time PCR results are expressed as the fold change 
increase in comparison to media control.
SRA surface expression—RAW 264.7 macrophages were treated with SPD-MAA (200 
µg/mL) for (1–24 h). After treatment, macrophages were washed with ice-cold PBS 
followed by fixation with 3.7 % paraformaldehyde for 10 min at 4°C. After fixation, 
macrophages were washed with PBS followed by incubation with rat anti-SRA labeled with 
FITC and matched isotype control antibody at 4°C for 1 h. After incubation macrophages 
were washed with PBS three times and the samples were analyzed by flow cytometry. Flow 
cytometry analysis was performed with FACS Calibur available in the UNMC Flow 
Cytometry Core (BD Biosciences, San Jose, CA).
Statistics—All data were analyzed using GraphPad Prism (version 5.00 for Windows; 
GraphPad Software, San Diego CA) and represented as mean ± SE. Data were analyzed for 
statistical significance using Student’s t-test and both one-way and two-way ANOVA 
employing Tukey's multiple comparison post-test corrections. A p-value less than 0.05 was 
regarded as statistically significant.
RESULTS
Cell viability
Cell viability was assessed by trypan blue exclusion method as described previously (Reissis 
et al., 2013). No cell death was observed for different concentrations of SPD-MAA over a 
period of 6–48 h as measured by trypan blue exclusion method. Also, the PKC alpha 
inhibitor, NF-κB inhibitor, fucoidan (a ligand for SRA) and anti-SRA did not affect cell 
viability (data not shown).
SPD-MAA exposure induces pro-inflammatory cytokine TNFα release
To determine whether exposure to SPD-MAA induces pro-inflammatory cytokine TNF-α 
release, RAW 264.7 macrophages were exposed to 200 µg/mL of SPD-MAA for different 
time points (6–48 h). RAW 264.7 macrophages produced TNF-α in response to SPD-MAA 
in a time-dependent manner. A significant increase (p < 0.0001) in TNF-α release was 
observed as early as 6 h in comparison to media control (Fig. 1A). Additionally, a dose-
dependent increase in TNF-α release was observed in response to SPD-MAA. TNF-α 
release was significantly increased (p < 0.001) following exposure to 100–200 µg/mL of 
SPD-MAA at 6 h (Fig. 1B). No significant increase in TNF-α release was observed when 
exposed to non-adducted lung surfactant protein SPD (Fig. 1B). These data demonstrate that 
SPD-MAA induces TNF-α release from RAW 264.7 macrophages in both a time- and 
concentration-dependent manner. Similarly, in peritoneal macrophages (PMs) isolated from 
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WT mice, we observed a significant dose-dependent (p < 0.0001) increase in TNF-α release 
at 6 h when treated with 200 µg/mL of SPD-MAA (Fig. 1C). No such response was 
observed in PMs from SRA−/− mice (Fig. 1C). In addition, significantly less TNF-α release 
was observed at 100 µg/mL (p < 0.05) and 200 µg/mL (p < 0.0001) of SPD-MAA treatment 
in SRA−/− mice in comparison to WT mice (Fig. 1C). Pretreatment blocking with fucoidan, 
a ligand for scavenger receptor A, significantly reduced (p < 0.001) SPD-MAA-induced 
TNF-α release in RAW 264.7 macrophages (Fig. 1D). No reduction in SPD-MAA 
stimulated TNF-α release was observed when macrophages were treated with fetuin, a 
glycoprotein negative control for fucoidan (data not shown). Treatment with SRA blocking 
antibody (2F8) significantly reduced (p < 0.001) SPD-MAA stimulated TNF-α release (Fig. 
1E). No reduction in SPD-MAA stimulated TNF-α release was observed when macrophages 
were treated with isotype-matched negative control, IgG (data not shown).
SPD-MAA exposure induces pro-inflammatory cytokine IL-6 release
To determine whether exposure to SPD-MAA induces pro-inflammatory cytokine IL-6 
release, PMs from both WT and SRA−/− mice were exposed to different doses of SPD-
MAA for 6 h. A significant increase in IL-6 was detected at the highest concentration of 
SPD-MAA (200 µg/mL) (p < 0.0001) (Fig. 2). No such increase was observed in PMs from 
SRA−/− mice. We also observed a significant attenuation of IL-6 release at 200 µg/mL of 
SPD-MAA (p < 0.0001) treatment in PMs from SRA−/− in comparison to WT mice (Fig. 2). 
No time or dose-dependent increase in IL-6 was observed when RAW 264.7 macrophages 
were exposed to SPD-MAA (200 µg/mL) for up to 24 h (data not shown).
Effect of SPD-MAA on phagocytosis of zymosan particles
To determine the role of SPD-MAA on phagocytic function, RAW 264.6 macrophages were 
incubated with 200 µg/mL SPD-MAA for 3 h followed by addition of zymosan particles for 
0–60 min. Treatment with SPD-MAA significantly decreased the phagocytosis of zymosan 
particles at 30 min (p < 0.0001) and 60 min (p < 0.0001) in comparison to their respective 
media control (Fig. 3A). No reduction was observed when macrophages were treated with 
non-adducted SPD only (Fig. 3A). A similar result was observed in PMs from WT mice 
treated with 200 ug/mL SPD-MAA for 3 h. In PMs, a significant increase in phagocytosis of 
zymosan at 30 min was observed in both media control (p < 0.0001) and SPD (p <0.0001) 
treatment groups when compared to 0 min (Fig. 3B). When treated with SPD-MAA, a 
significant decrease in phagocytosis (p < 0.0001) was observed at 30 min when compared to 
media control and non-adducted SPD treatments (Fig. 3B). The different letters (a,b) are 
used to indicate the significance from their respective treatment group at 0 min (Fig. 3B).
Effect of SPD-MAA on superoxide ion and nitrite release
To determine the role of SPD-MAA on superoxide ion and nitrite ion release, RAW 264.6 
macrophages were pre-incubated with 200 µg/mL SPD-MAA for 24 h followed by addition 
of PMA (300 ng/mL) for 1 h or opsonized zymosan for 30 min. SPD-MAA significantly 
reduced superoxide ion release from RAW 264.7 macrophages in response to zymosan (p < 
0.001; Fig. 4A). A similar result was observed in response to PMA (p < 0.001; Fig. 4B). Pre-
treatment with non-adducted SPD had no such effect (Fig. 4A and 4B). To measure nitrite 
release, RAW 264.7 macrophages were pre-treated with 200 ug/mL of SPD-MAA for 3 h 
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followed by the addition of zymosan (0.3 mg/mL) for another 24 h. SPD-MAA significantly 
reduced (p < 0.01) nitrite release in response to zymosan (Fig. 4C). No reduction in nitrite 
release was observed when exposed to equal concentration of SPD (Fig. 4C).
Effect of SPD-MAA on SRA expression
To determine the effect of SPD-MAA on SRA message expression, RAW 264.6 
macrophages were treated with 200 µg/mL SPD-MAA for 1, 3, 6, and 24 h and later 
analyzed for SRA mRNA expression. A significant up regulation of SRA mRNA expression 
was observed at 6 h (p < 0.0278; Fig. 5A). At 24 h, however, SRA mRNA expression 
returned to baseline. No such effect on SR-A mRNA was seen when RAW 264.6 cells were 
treated with SPD for 6 h (Fig. 5A).
To determine the effect of SPD-MAA on surface expression of SRA, RAW 264.6 
macrophages were treated with 200 µg/mL SPD-MAA for 0–24 h and analyzed for surface 
receptor expression by flow cytometry. No significant change in SRA surface expression 
was detected at 1, 3, 6, or 24 h (Fig. 5B). No rapid transient change in SRA expression was 
observed at 0–30 min (data not shown).
MAA-adducted protein binds to SRA and causes PKC activation
To identify the role of PKC on SPD-MAA induced pro-inflammatory cytokine release, RAW 
264.7 macrophages were incubated with different PKC isoform inhibitors at 1 µM 
concentration (40) for 1 h before addition of 200 µg/mL SPD-MAA for 6 h. PKC alpha 
inhibitor Gö 6976 pretreatment significantly decreased TNFα release from RAW 264.7 
macrophages in response to SPD-MAA (p < 0.001; Fig. 6A). No other PKC inhibitors 
affected TNF-α release (Fig 6A). A similar result was observed when PMs from WT mice 
were pretreated with PKC alpha inhibitor Gö 6976 for 1 h (p < 0.05) (Fig. 6B). In addition to 
TNFα, pretreatment with Gö 6976 also significantly decreased IL-6 release from PMs 
macrophages from WT mice in response to SPD-MAA at 6 h (p < 0.001) (Fig. 6C).
MAA-adducted protein binds to SRA and causes NF-κB activation
To identify the role of transcription factor NF-κB on SPD-MAA induced pro-inflammatory 
cytokine release, RAW 264.7 and PMs were incubated with the NF-κB inhibitor 
parthenolide at 1 µM concentration for 1 h before addition of 200 µg/mL SPD-MAA for 6 h. 
Parthenolide at the concentration used had no cytotoxic effect and did not induce apoptosis 
and oxidative stress (Tiuman et al., 2005; Wen et al., 2002). A significant reduction in TNF-
α release was observed in both RAW 264.7 macrophages (p < 0.001; Fig. 7A) and PMs (p < 
0.01; Fig. 7B). In addition to TNF-α, pretreatment with NF-κB inhibitor, parthenolide, 
significantly reduced IL-6 release from PMs at 6 h in response to SPD-MAA (p < 0.001; 
Fig. 7C).
DISCUSSION
It is well established that macrophages play an important role in immunity. Therefore any 
alterations in macrophage function can lead to inflammation, injury and infection. 
Acetaldehyde and malondialdehdye derived MAA adducts have been shown to induce the 
Sapkota et al. Page 8
Alcohol Clin Exp Res. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
release of pro-inflammatory cytokines and chemokines by kupffer, endothelial, and stellate 
cells of the liver (Duryee et al., 2004; Kharbanda et al., 2001). In this study, we 
demonstrated that MAA adduct effects macrophage functions. Our study shows that SPD-
MAA, a MAA adduct to surfactant protein D, activates both RAW 264.7 and peritoneal 
macrophages to release pro-inflammatory cytokines TNF-α and IL-6. In addition to this, our 
study also shows that MAA adduct affects phagocytic function as well as superoxide ion and 
nitrite ion release, which were not studied previously. Our study also showed that PKC alpha 
and NF-κB may be important for MAA-stimulated TNF-α and IL-6 release.
Our data extend the concept that MAA adducts have a pro-inflammatory effect. MAA 
adducts have been shown to induce pro-inflammatory cytokine TNF-α in a purified rat heart 
endothelial cell culture (HEC)(Hill et al., 1998) and stimulate TNF-α, monocyte chemo-
attractant protein-1 (MCP-1), and macrophage inflammatory protein-2 (MIP-2) in liver 
endothelial cells (Thiele et al., 2004). Interestingly, our study showed higher levels of TNF-
α release from PMs than from RAW 264.7 macrophages. Unlike TNF-α, only very high 
concentrations of SPD-MAA stimulated IL-6 release from PMs. Differences in both 
cytokine expression and response between primary macrophages and immortalized 
macrophage cell lines could explain this result (Chamberlain et al., 2009).
Our data suggest a role for PKCα, a calcium-dependent classical protein kinase C isoform 
and transcription factor NF-κB, in pro-inflammatory cytokine release in response to SPD-
MAA from RAW 264.7 and PMs. Other PKC isoform-specific inhibitors failed to inhibit 
TNF-α release. This is in contrast with our previous finding in epithelial cells (Berger et al., 
2014) where PKC epsilon was involved in the MAA mediated pro-inflammatory cytokine 
release. This could be due to difference in cell type involved and cytokine measured (KC). In 
our study, PKC alpha inhibitor does not totally inhibit TNF alpha and IL-6 release when 
compared to untreated cells. This may suggest other signaling pathway like p38/JNK as 
suggested by others (Nikolic et al., 2011; Ben et al., 2013; Hsu et al., 2001) involved in 
addition to PKC alpha.
In our study, the dose of MAA used is higher than required for airway cells (100 ug/mL) 
(Berger et al., 2014) and the amount detected (500 ng/mL)(McCaskill et al., 2011) in lung of 
mice after exposure to alcohol and cigarette smoke for 8 weeks. But, this is the amount 
detected only after 8 weeks exposure, and people abuse alcohol and smoke cigarette for 
years. Therefore the amount of adduct formed in their lung could be much higher than 
detected in the mice.
Our study also reportS that SPD-MAA significantly reduces the phagocytic function of 
macrophages in RAW 264.7 and peritoneal macrophages. A significant reduction in 
superoxide ion and nitrite ion release was observed when RAW 264.7 macrophages were 
exposed to SPD-MAA. Alcohol has been previously reported to reduce phagocytic function, 
antimicrobial activity, superoxide ion, and nitric oxide release from macrophages (Satapathy 
and Shrivastava, 2012; Castro et al., 1993; Szabo, 1999; D'Souza et al., 1996; Libon et al., 
1993; Andrade et al., 2008). Our findings may suggest MAA adduct formation could be one 
of the mechanisms through which alcohol may exert such actions.
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Our study shows that SPD-MAA mediates effects in both RAW 264.7 and PMs through 
scavenger receptor A. Only a few previous studies have examined a role for scavenger 
receptor in MAA mediated effects in mice and bronchial epithelial cells (Thiele et al., 2001). 
Our study further identified a role for SRA in SPD-MAA mediated pro-inflammatory 
cytokine release in macrophages. TNF-α and IL-6 release was significantly reduced in SRA
−/− PMs in comparison to cells from WT mice. Pretreatment with fucoidan (a ligand that 
competes with SPD-MAA for scavenger receptor) or SRA blocking antibody significantly 
reduced SPD-MAA induced TNF-α release from RAW 264.7 macrophages. These results 
suggest that the SPD-MAA adduct most likely binds to SRA and signals the release of 
cytokines in both RAW 264.7 and PMs. In addition, MAA-mediated reduction in phagocytic 
function was also SRA-dependent. Our results from PMs from SRA−/− mice imply that 
SRA is important for MAA adduct binding resulting in the modulation of zymosan 
phagocytosis.
We also report that exposure to SPD-MAA induced SRA mRNA expression in RAW 264.7 
macrophages. Although SRA mRNA expression is increased, no change in surface 
expression of SRA at any time point tested was observed. This finding is in contrast with our 
previous finding in airway cells where a transient decrease in SRA surface expression was 
observed after short-term exposure to MAA (Berger et al., 2014). This could be due to 
difference in the cell type involved. Also. SPD-MAA being a ligand for SRA, may induce 
gene expression and subsequent receptor secretion. But due to rapid binding of MAA to the 
newly expressed receptors, no change in surface receptor expression could be observed even 
though new SRA receptors are secreted (Murphy et al., 2005).
A major limitation of our study is that our results are limited to RAW 264.7 and peritoneal 
macrophages. Because SPD is a lung defense protein shown to be the target of MAA 
adduction, primary lung macrophages would have been ideal to further confirm SPD-MAA 
effects observed in RAW 264.7 cells and PMs, but they were difficult to obtain in sufficient 
viable numbers (500,000 cells per well) to perform the extensive studies reported in the 
current study. In addition, a large number of mice (30–50) were required to obtain enough 
cells to conduct a single experiment. It is important to note that MAA adduct formation can 
involve a wide variety of target proteins and the MAA moiety has itself been shown to be 
inflammatory and immunogenic (Wyatt et al., 2012). So several previous studies have 
utilized non-biologically relevant proteins such as BSA for lung and liver studies (Wyatt et 
al., 2012; Wyatt et al., 2001; Kharbanda et al., 2001; Thiele et al., 2004). Therefore all 
studies were done in RAW 264.7 and peritoneal macrophages. To overcome the above-
mentioned limitation, future in-vivo studies using WT and SRA−/− mice is necessary to 
further confirm results observed in both macrophages and airway epithelial cells. This will 
also justify the role of SRA in SPD-MAA mediated lung effects.
To summarize, our current study demonstrates that MAA adducted proteins modulate certain 
macrophage inflammatory and effector functions in RAW 264.7 and PMs. Such modulations 
may involve secretion of pro-inflammatory cytokines such as TNF-α and IL-6 as well as 
compromised phagocytic and superoxide and nitrite ion release. Additionally, our study also 
emphasizes the functional role of SRA in mediating the effects of SPD-MAA since in the 
absence of SRA, MAA failed to reduce macrophage function. Our data also suggest that 
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PKCα and NF-κB play roles in MAA adduct-stimulated pro-inflammatory cytokine release 
by these macrophages.
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Figure 1. Effect of SPD-MAA on pro-inflammatory cytokine TNF-α release
TNFα release from RAW 264.7 macrophages was measured after treatment with 200 µg/mL 
SPD-MAA for 6, 24 and 48 h (A). After treatment, supernatant was collected and TNF-α 
level measured by ELISA. SPD-MAA induced TNF-α release from RAW 264.7 (B) and 
wild type peritoneal macrophages (C) in concentration dependent manner at 6 h. No such 
effect was seen in SRA−/− mice (C). RAW 264.7 macrophages were pretreated with 50 
µg/mL of fucoidan (D) for 72 h or 10 µg /mL of Anti-SRA (E) for 24 h followed by 
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treatment of SPD-MAA for 6 h. Values are the mean ± SEM of three independent 
experiments.
Sapkota et al. Page 15
Alcohol Clin Exp Res. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Effect of SPD-MAA on pro-inflammatory cytokine IL-6 release
Peritoneal macrophages (PMs) from wild type (WT) and SRA−/− mice were treated 200 
µg/mL SPD-MAA for 6 h. After treatment, supernatant media was collected and IL-6 levels 
measured by ELISA. SPD-MAA induced IL-6 release from PMs from WT mice at highest 
concentration at 6 h. No such effect was seen on PMs from SRA−/− mice. Values represent 
mean ± SEM of three independent experiments.
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Figure 3. Effect of SPD-MAA on phagocytosis of zymosan particles
RAW 264.7 macrophages and peritoneal macrophages (PMs) were treated with 200 µg/mL 
of SPD-MAA for 3 h followed by addition of zymosan particles for (0–60) min. 
Phagocytosis of the particles was detected as described in methods. SPD-MAA treated 
significantly reduced the phagocytosis of particles by RAW 264.7 macrophage (A) and PMs 
(B) from wild type (WT) mice (white bars). No such effect was seen in PMs from SRA−/− 
mice (B; black bars). Values represent mean ± SEM of three independent experiments. The 
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different letters (a,b) are used to indicate the significance from their respective treatment 
group at 0 min.
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Figure 4. Effect of SPD-MAA on nitrite and superoxide ion release
RAW 264.7 macrophages were pretreated with 200 µg/mL SDP-MAA for 24 h followed by 
treatment with PMA (300 ng/mL) for 1 h (A) or opsonized zymosan (1 mg/mL) for 30 min 
(B). After treatment time superoxide ion was measured using NBT method. For nitrite 
release, RAW 264.7 macrophages were pretreated with 200 µg/mL SDP-MAA for 3 h 
followed by treatment with zymosan (0.3 mg/mL) for another 24 h. After 24 h supernatant 
was collected and nitrite level measured (C). Values represent mean ± SEM of three 
independent experiments
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Figure 5. Effect of SPD-MAA on SR-A expression
RAW 264.7 macrophages were treated with SPD-MAA for (1–24 h) and later analyzed for 
SRA message (A) expression by RT-PCR. Results represent fold change in SRA message 
expression from media control. RAW 264.7 macrophages treated with SPD-MAA (0–24 h) 
and later analyzed for SRA surface receptor expression by flow cytometry (B). Values 
represent mean ± SEM of three independent experiments.
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Figure 6. Effect of PKC isoform inhibitors on SPD-MAA stimulated TNF-α and IL-6 release
RAW 264.7 macrophages (A) were pretreated with different PKC isoform inhibitors at 1 µM 
concentration for 1 h before addition of 200 µg/mL SPD-MAA for 6 h (A). PMs from WT 
mice were pretreated with PKC alpha inhibitor Gö 6976 (1uM) for 1 h and later treated with 
200 µg/mL SPD-MAA or SPD for 6 h. After treatment, supernatant was collected and TNFα 
(A, B) or IL-6 (C) levels were measured by ELISA. Values are the mean ± SEM of three-six 
independent experiments. Legend same for all 3 figures.
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Figure 7. Effect of NF-κB inhibitor on SPD-MAA stimulated TNFα and IL-6 alpha release
RAW 264.7 macrophages (A) were incubated with NF-κB inhibitor (parthenolide) at 1 µM 
concentration for 1 h before addition of 200 µg/mL SPD-MAA for 6 h (A). PMs from WT 
mice were pretreated parthenolide (1uM) for 1 h and later treated with 200 µg/mL SPD-
MAA for 6 h SPD (B, C). After treatment, supernatant was collected and TNF-α (A, B) and 
IL-6 (C) levels were measured by ELISA. Values are the mean ± SEM of three independent 
experiments. Legend same for all 3 figures.
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Figure 8. Proposed model
Hybrid adduct SPD-MAA in the lung binds to SRA expressed on the macrophage surface 
and modulates macrophage functions. SPD-MAA exposure decreases phagocytosis, 
superoxide ion and nitrite release as well as increases pro-inflammatory cytokines TNF-α 
and IL-6 release. Using SRA competing ligand fucoidan, SRA ligand blocking antibody or 
knocking out SRA gene diminishes these modulations. PKC alpha inhibitor Gö 6976 and 
NF-κB inhibitor parthenolide inhibited pro-inflammatory cytokines release from 
macrophage in response to SPD-MAA.
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